Palmlund I, Apfel R, Buitendijk S, Cabau A, Forsberg J G
Department of International Health Care Research (IHCAR), Karolinska Institutet, Stockholm, Sweden.
J Psychosom Obstet Gynaecol. 1993 Mar;14(1):71-89. doi: 10.3109/01674829309084432.
This article is a report based on presentations at the symposium Effects of Diethylstilbestrol (DES) Medication during Pregnancy at the conference Reproductive Life, 10th International Congress of The International Society of Psychosomatic Obstetrics and Gynaecology (ISPOG) in Stockholm, Sweden June 14-17, 1992. The objective of this symposium, chaired by Eylard van Hall and Ingar Palmlund, was to provide the basis for a discussion of how the risks of DES had been evaluated in different countries. In the general discussion following the presentations everybody present expressed concerns that DES might still be given to pregnant women in many parts of the world, called for measures to alert medical professionals world-wide to the hazards of the use of DES, and requested measures to effect an international ban of DES in medication for pregnant women.
本文是一份报告，基于1992年6月14日至17日在瑞典斯德哥尔摩举行的第10届国际心身性妇产科学会（ISPOG）生殖生活会议上关于孕期服用己烯雌酚（DES）影响的专题研讨会的发言内容。本次由埃拉德·范·霍尔和英格·帕尔姆伦德主持的专题研讨会的目的是为讨论如何在不同国家评估DES的风险提供依据。在发言后的一般性讨论中，与会的每个人都表达了对世界许多地区可能仍在给孕妇使用DES的担忧，呼吁采取措施提醒全世界的医学专业人员注意使用DES的危害，并要求采取措施在国际上禁止将DES用于孕妇用药。
